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a  b  s  t  r  a  c  t
Multiple  sclerosis  (MS)  is a chronic  neurological  disease,  frequently  affecting  attention  and  working
memory  functions.  Functional  imaging  studies  investigating  those  functions  in MS patients  are  hard  to
compare,  as  they  include  heterogeneous  patient  groups  and  use  different  paradigms  for cognitive  test-
ing.  The  aim  of this  study  was  to investigate  alterations  in  neuronal  activation  between  MS  patients  and
healthy  controls  performing  attention  and  working  memory  tasks.  Two meta-analyses  of previously  pub-
lished  fMRI  studies  investigating  attention  and  working  memory  were  conducted  for  MS patients  and
healthy  controls,  respectively.  Resulting  maps  were  contrasted  to compare  brain  activation  in  patients
and  healthy  controls.  Signiﬁcantly  increased  brain  activation  in the  inferior  parietal  lobule  and  the  dor-ttention
ctivation likelihood estimation
LPFC
LPFC
-Back
solateral  prefrontal  cortex  was  detected  for healthy  controls.  In  contrast,  higher  neuronal  activation
in  MS  patients  was  obtained  in  the left  ventrolateral  prefrontal  cortex  and  the right premotor  area.
With  this  meta-analytic  approach  previous  results  of  investigations  examining  cognitive  function  using
fMRI  are  summarized  and  compared.  Therefore  a more  general  view  on cognitive  dysfunction  in this
heterogeneous  disease  is  enabled.ASAT
VSAT
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. Introduction
Multiple Sclerosis (MS) is an inﬂammatory and neurodegener-
tive disease of the central nervous system (CNS) characterized
redominantly by demyelinating lesions in the white matter of the
rain and the spinal cord. Conventional structural magnetic res-
nance imaging (MRI) can be used to identify and quantify these
esions. Furthermore, focal demyelination and neuronal loss of gray
atter, appearing as partly or entirely cortically located lesions on
RI  images as well as structural damage of white and gray mat-
er appearing normal on conventional MRI  images are components
f the disease (Lassmann, 2008). A hallmark of CNS lesions char-
cteristic for MS  is disseminations in both space and time. Due to
patially disseminated damage to the CNS, MS  results in a wide
pectrum of clinical manifestations ranging from motor symptoms
o cognitive and neuropsychiatric deﬁcits. Disease onset peaks
etween 22 and 30 years and women are affected approximately
wice as often as men  (Alonso and Hernán, 2008).
The different clinical courses of MS  can be categorized into four
ypes based on disease progression (Lublin and Reingold, 1996):
elapsing-remitting MS  (RRMS) which is characterized by clearly
eﬁned relapses with full recovery or sequelae and residual defects.
uring periods between relapses the disease does not progress
linically. In case this phenotype of the disease is followed by a
rogression with or without occasional relapses, minor remissions,
nd plateaus it is classiﬁed as secondary progressive MS (SPMS). In
ontrast, primary progressive MS  (PPMS) takes a progressive course
rom the beginning with plateaus and temporary minor improve-
ents. The fourth type is progressive-relapsing MS  (PRMS), which
s progressive from the onset with acute relapses. Between the
elapses there is continuing progression. Superimposed relapses
ay occur in SPMS, whereas in PPMS no acute relapses occur
patients with relapses are then categorized as having PRMS; Lublin
nd Reingold, 1996).
Among  the clinical symptoms which affect all types of MS
ognitive impairment is the most common symptom with preva-
ence rates between 43% and 70% signiﬁcantly contributing to the
xtent of disability (Benedict et al., 2006; Peyser et al., 1990; Rao
t al., 1991). Memory, attention, processing speed, information
rocessing efﬁciency, and executive functioning have been shown
o be the cognitive capacities that are most frequently impaired
Benedict et al., 2006; Rao et al., 1991).
Functional MRI  (fMRI) has been used to identify brain regions
hat are on the one hand involved in cognitive functioning in
ealthy individuals and on the other hand showing altered acti-
ation in MS.  FMRI studies that explored cognitive processes in
S examined a great variety of functions, such as working mem-
ry, attention, and executive functions (Chiaravalloti and DeLuca,
008) using paradigms such as the Paced Auditory Serial Addition
est (PASAT; e.g. Audoin et al., 2005; Forn et al., 2006; Mainero
t al., 2004), the Paced Visual Serial Addition Test (PVSAT; Bonzano
t al., 2009), and the n-Back task (e.g. Amann et al., 2011; Cader
t al., 2006; Forn et al., 2007; Sweet et al., 2004). These abili-
ies were not only examined in behavioral studies, but also using
unctional imaging to explore the neuronal correlates of impaired
erformance.
During the last years, the number of functional imaging stud-
es rapidly increased as the neuroscience community urged to
ain more detailed insight into diseases progression and prog-
osis, as well as therapeutic options. However, results of these
tudies are hardly comparable, as typically stimulation paradigms,
isease phenotypes, and statistical evaluation of fMRI data show
uge variability. Therefore, the current study aimed at providing an
verview of previous literature in conjunction with the mapping of
unctional brain activity related to attention and working memory
unction in MS  patients with high statistical probability performingavioral Reviews 37 (2013) 2699–2708
meta-analyses in order to present a comparison of neuronal activity
patterns of MS  patients with those of healthy controls.
2.  Materials and methods
2.1.  Study selection
For  this meta-analysis peer-reviewed studies on functional neu-
roimaging of attention and working memory processes in patients
with multiple sclerosis, published in the English language between
1996 and February 2013 were identiﬁed.
Literature research was  performed using PubMed, an online
database including more than 22 million citations for biomedical
literature using the following keywords: functional MRI;  positron
emission tomography; multiple sclerosis (including common abbre-
viations like fMRI, PET, and MS); which were cross-referenced with
the search terms cognition; information processing speed; memory;
working memory; executive functions; selective; focused or sustained
attention; and attention. In addition, we used search terms for tasks
associated with working memory and attention like n-Back; Paced
Auditory Serial Addition Test; and Paced Visual Serial Addition Test
(including the common acronyms PASAT and PVSAT) as cross-
reference. In a second step, the reference lists of the original articles
resulting from this search were examined in order to ﬁnd additional
publications that were not identiﬁed by the database search.
For  the current meta-analysis the following seven inclusion
criteria were speciﬁed:
1.  Studies must include patients with diagnosed multiple sclero-
sis,  studies including patients with Clinically Isolated Syndrome
(CIS)  with the diagnosis “possible MS”  were excluded.
2. Included studies had to focus on attention and working mem-
ory  processes by using auditory or visually presented stimuli.
Studies,  that used cognitive paradigms investigating attention
in  conjunction with higher cognitive abilities, such as response
inhibition, were excluded.
3. The studies had to examine neuronal activity in working memory
and/or  attention tasks with means of functional magnetic reso-
nance  imaging (fMRI) or positron emission tomography (PET).
4. As contrasts used for fMRI or PET analysis we  only included direct
comparisons  between attention or working memory task against
a  baseline condition for MS  patients and healthy controls sepa-
rately.  Comparisons between healthy controls and MS  patients
without  reporting brain activation for each group separately
were  not included.
5. Only studies reporting coordinates of a whole-brain analysis for
patients and healthy controls separately were included. Stud-
ies  reporting only results of regions of interest (ROI) analyses,
volume of interest (VOI) analyses, or small volume correction
(SVC)  were excluded. Also, studies that reported only correla-
tions  of BOLD signal changes with respect to other measures
were  excluded.
6. All reported results had to be corrected for multiple testing at a
signiﬁcance level of p < 0.05, uncorrected data had to be thresh-
olded  at p < 0.005.
7.  Included coordinates had to be reported in either standard
Talairach space or the Montreal Neurologic Institute (MNI) space.
2.2. Activation likelihood estimation
Activation likelihood estimation (ALE) meta-analyses
(Turkeltaub  et al., 2002, 2012; Laird et al., 2005; Eickhoff
et al., 2012), were performed using GingerALE 2.1
(www.brainmap.org/ale). If necessary, neuroanatomical coor-
dinates  reported in MNI  space were transformed to Talairach
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Table  1
Neuroimaging studies of attention and working memory processes in multiple sclerosis.
Author, year Healthy controls Patients Disease
duration (y)
Type of disease Cognitive
paradigm
No of foci Stereotactic
space
Age (years) N (f/m) Age (years) N (f/m) Controls Patients
Amann et al., 2011 33.9 15 (5/10) 37.6 15 (9/6) 5.9 RRMS n-Back 39 39 TAL
Bonzano  et al., 2009 18 32.5 23 (11/12) 6.9 RRMS PVSAT 16 11 TAL
Cader  et al., 2006 39.0 16 (10/6) 39.0 21 (15/6) 6.0 RRMS/RPMS n-Back 8 8 MNI
Forn  et al., 2007 10 (5/5) 17 (12/5) RRMS n-Back 10 10 TAL
Forn  et al., 2006 31.1 10 (5/5) 32.7 15 (11/4) RRMS PASAT 8 14 TAL
Li  et al., 2004 40.6 5 47.8 8 Auditory
working
memory task
6 2 TAL
Mainero  et al., 2004 22 (11/11) 30.5 22 (14/8) 9.0 RRMS PASAT/recall
task
62 67 TAL
Penner  et al., 2003 7 45.8 14 (13/1) 11.4 RRMS/SPMS n-Back 9 22 TAL
Sumowski  et al., 2010 − − 43.8 18 (15/3) 9.5 RRMS/SPMS n-Back − 28 TAL
Total  103 153 158 201
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wRMS, relapsing-remitting multiple sclerosis; RPMS, relapsing-progressive multipl
ttention  task; PVSAT, paced visual serial attention task.
pace (Talairach and Tournoux, 1988) using icbm2tal transfor-
ation (Lancaster et al., 2007; Laird et al., 2010) implemented in
ingerALE.
The ALE technique uses peak coordinates reported in func-
ional neuroimaging studies as Gaussian probability distributions.
he ALE algorithm is based on random-effects interference and
ontrols for sample size by including the number of subjects in
ach study into calculation (Eickhoff et al., 2009). First, a whole-
rain ALE map  is created by estimating the likelihood of activation
f each voxel. In the next step, the calculated ALE values are
ested against the null hypothesis by using permutation testing
Eickhoff et al., 2012). The resulting statistical maps are thresh-
lded at p < 0.05 and corrected for multiple testing using the false
iscovery rate (FDR). In the last step, GingerALE performs a cluster
nalysis based on the thresholded map  with a minimum clus-
er size of 200 mm3. Separate meta-analyses were performed for
atients and healthy controls. Finally, the resulting ALE maps for
ach group were subtracted from each other. Individual ALE maps
ere thresholded at a conservative level of p < 0.05 (FDR corrected),
herefore a voxel-level threshold of p < 0.05 (uncorrected) was  used
or subtraction analyses to avoid inﬂating false negative results. To
ontrol for inordinate inﬂuence of one single study, further meta-
nalyses were performed, using a leave-one-out cross-validation
rocedure.
For visualization, whole-brain maps of thresholded ALE
aps were imported into Multi-image analysis GUI (MANGO;
ttp://ric.uthscsa.edu/mango) and overlaid onto a standardized
natomical template in Talairach space (colin1.1.nii; Laird et al.,
005).
. Results
.1. Literature review
Based  on the systematic review of literature, a total of 42 articles
hat explored working memory and/or attention networks in MS
sing either fMRI or PET were identiﬁed. However, only nine studies
n total, all using fMRI, fulﬁlled all inclusion criteria speciﬁed in the
ethod section (see Table 1). These studies provided a total of 158
oci for healthy controls and 201 foci for patients with multiple scle-
osis. Six of the included studies used correction for multiple testing
t the peak- or cluster-level. The remaining three papers reported
ncorrected p-value thresholds, the least conservative threshold
as p < 0.005 uncorrected (one study).osis; SPMS, secondary progressive multiple sclerosis; PASAT, paced auditory serial
For visualization of homogeneity of the included studies, all
reported foci were presented in Talairach space for healthy controls
and MS  patients separately (Fig. 1A and B).
3.2. Signiﬁcant ALE values for working memory and attention in
healthy controls
The  ALE analysis of healthy subjects revealed 17 signiﬁcant clus-
ters for working memory and attention tasks (Table 2 and Fig. 2).
We found signiﬁcant ALE scores bilaterally in the dorsolateral and
ventrolateral prefrontal cortex (DLPFC, VLPFC). ALE analysis further
revealed signiﬁcant clusters in the frontal eye ﬁeld and the inferior
parietal lobule, two  areas responsible for visual attention. More-
over, signiﬁcant ALE values were obtained in the insular cortex and
in the thalamus.
3.3.  Signiﬁcant ALE values for working memory and attention in
MS patients
For MS  patients, ALE analysis obtained 24 statistically signiﬁcant
clusters related to working memory and attention tasks (Table 3
and Fig. 3). Similar to healthy controls, large signiﬁcant clusters
were found in the DLPFC and VLPFC, and in the inferior parietal
lobule. Furthermore, ALE analysis revealed signiﬁcant clusters in
the superior and middle temporal gyri and in the insular cortex.
3.4.  Comparison of ALE maps for healthy controls and MS patients
To investigate differences between MS  patients and healthy con-
trols, we  calculated contrasts for the ALE maps of healthy controls
versus MS  patients and MS  patients versus healthy controls. Signif-
icant ALE values related to higher likelihood of activation in healthy
controls were found bilaterally in the inferior parietal lobule and
the DLPFC as well as in the right VLPFC (Table 4 and Fig. 4). For
the reverse contrast, indicating increased likelihood of activation
in MS  patients clusters were obtained in the left VLPFC and the
right premotor area (Table 5 and Fig. 4).
3.5. Testing of robustness of ALE mapsDue to the small number of included studies, one single study
may inﬂuence resulting ALE maps excessively. Therefore, we  per-
formed nine additional meta-analyses, removing one single study
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colin1.1.nii) in axial orientation, referring to Talairach space. Voxel-size for all foci 
green) separately. (For interpretation of the references to color in this ﬁgure legen
rom the data set. The results of this cross-validation procedure
evealed high consistency of signiﬁcant ALE maps (see Fig. 5).
.  Discussion
The aim of this review was to explore differences in brain activa-
ion between MS  patients and healthy controls induced by working
emory and attention tasks using the statistical power of a meta-
nalytic approach. Results of the ALE meta-analysis revealed the
ighest likelihood for activation in main attention and working
emory related brain areas, such as the DLPFC and VLPFC and the Peak-voxels of included studies are projected on a standard anatomical template
t to 4x4x4 mm.  Foci are reported for (A) healthy controls (red) and (B) MS patients
reader is referred to the web version of this article.)
inferior  parietal lobule in healthy controls and MS  patients. How-
ever, we found signiﬁcantly increased activation bilaterally in the
inferior parietal lobule and the DLPFC as well as the right VLPFC for
healthy controls. In contrast, MS  patients showed higher activation
in the left VLPFC and the right premotor area.
Domains, typically impaired in MS  patients are working
memory, information processing speed and executive functions,
including attention (for review see Lovera and Kovner, 2012).
Additionally, the neuropsychological assessment of these abilities
can easily be implemented in an fMRI setup so that we decided
to only include fMRI studies investigating attention and working
K. Kollndorfer et al. / Neuroscience and Biobehavioral Reviews 37 (2013) 2699–2708 2703
Table  2
Signiﬁcant FDR corrected ALE values for healthy controls.
Cluster number Cluster volume (mm3) ALE value Talairach coordinates Anatomical label
x y z
1 3448  0.02 −50 6 38 Middle Frontal Gyrus
0.02  −40 2 38 Middle Frontal Gyrus
0.01 −40 24  30 Middle Frontal Gyrus
0.01 −48  2 48 Precentral Gyrus
2 2664  0.02 −32 14 8 Insular Cortex
0.02  −34 22 −2 Inferior Frontal Gyurs
3 2432  0.02 42 20 30 Middle Frontal Gyrus
0.02  38 34 30 Superior Frontal Gyrus
0.01 40  42 20 Middle Frontal Gyrus
4 2392  0.02 −34 −42 42 Inferior Parietal Lobule
0.02  −30 −52 38 Superior Parietal Lobule
0.01 −32 −60 36 Angular Gyurs
5 1888  0.02 32 −58 44 Superior Parietal Lobule
0.02 40 −52 42 Inferior Parietal Lobule
0.01  38 −42 38 Supramarginal Gyrus
6 1464  0.02 8 22 42 Cingulate Gyrus
0.02  4 10 50 Superior Frontal Gyrus
7 1240 0.02 10 0 56 Medial Frontal Gyrus
0.01 0  −2 58  Medial Frontal Gyrus
8 1192  0.02 42 18 −2 Inferior Frontal Gyurs
0.01 42 8 10 Insular Cortex
0.01  34 16 2 Insular Cortex
9  1008 0.02 −40 −60 −22 Cerebellum (declive)
10  672 0.02 32 −8 50 Precentral Gyrus
11 632  0.01 −26 4 52 Middle Frontal Gyrus
0.01  −34 6 56 Middle Frontal Gyrus
12  536 0.01 42 −50 −28 Cerebellum (culmen)
13  352 0.01 48 −32 4 Superior Temporal Gyrus
14 328 0.01 22  0 18 Lentiform Nucleus (putamen)
15 320 0.01 −16 −4 10 Lentiform Nucleus
16 264  0.01 −63 −30 10 Superior Temporal Gyrus
0.01 −62 −34 16 Superior Temporal Gyrus
17 208 0.01 16 −14 8 Thalamus (ventral lateral nucleus)
Fig. 2. Localization of signiﬁcant ALE values (p < 0.05, FDR corrected) due to attention and working memory tasks in healthy controls. ALE clusters are projected on a standard
anatomical template (colin1.1.nii) in axial orientation, referring to Talairach space.
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Table  3
Signiﬁcant FDR corrected ALE values for MS  patients.
Cluster number Cluster volume (mm3) ALE value Talairach coordinates Anatomical label
x y z
1 2968  0.02 −32 34 26 Middle Frontal Gyrus
0.02  −44 26 14 Inferior Frontal Gyrus
0.02  −42 26  22 Middle Frontal Gyrus
2  2376 0.02 46 −44 44 Inferior Parietal Lobule
3 2016  0.02 −42 −42 44 Inferior Parietal Lobule
0.02  −44 −48 38 Inferior Parietal Lobule
4 1896  0.02 2 14 54 Superior Frontal Gyrus
0.01 0 8 44 Medial Frontal Gyrus
0.01 0 2 52 Medial Frontal Gyrus
5  1616 0.02 42 28 30 Middle Frontal Gyrus
6  1592 0.03 34 18 2 Insular Cortex
7  1040 0.02 −36 −56 −26 Cerebellum (culmen)
8 976  0.02 55 −24 −2 Superior Temporal Gyrus
0.02 60 −18 −2 Superior Temporal Gyrus
9 968 0.02 52 6 40 Middle Frontal Gyrus
10  944 0.02 −30 −8 46 Middle Frontal Gyrus
11  672 0.02 −8 18  34 Cingulate Gyrus
12  600 0.02 −30 16 10 Insular Cortex
13  576 0.02 32 −76 −32 Cerebellum (pyramis)
14  496 0.02 30 −54 −28 Cerebellum (anterior lobe)
15 400 0.01 32 8 52 Middle Frontal Gyrus
0.01  30 2 46 Middle Frontal Gyrus
16 392  0.01 −59 −25 0 Superior Temporal Gyrus
0.01 −58 −20 −1 Middle Temporal Gyrus
17 336 0.02 −34 −74 −36 Cerebellum (inferior semi-lunar lobule)
18  328 0.02 −24 −64 44 Superior Parietal Lobule
19 320 0.01 38 −4 50 Middle Frontal Gyrus
20  280 0.01 38 −34 24 Insular Cortex
21  240 0.01 −34 22 0 Insular Cortex
22  232 0.01 −46 2 46 Precentral Gyrus
23  216 0.01 20 2 12 Lentiform nucleus (putamen)
24 208 0.01 −4 −48 10 Posterior Cingulate Gyrus
0.01 2 −52 8 Posterior Cingulate Gyrus
Fig. 3. Localization of signiﬁcant ALE values (p < 0.05, FDR corrected) due to attention and working memory tasks in MS patients. ALE clusters are projected on a standard
anatomical template (colin1.1.nii) in axial orientation, referring to Talairach space.
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Table  4
Signiﬁcant ALE values for the contrast healthy > patients.
Cluster number Cluster volume (mm3) ALE value Talairach coordinates Anatomical label
x y z
1 824 2.60 −53 5 36 Precentral Gyrus
2.29  −44 8 38 Middle Frontal Gyrus
2  712 2.59 38 −58 40 Inferior Parietal Lobule
3 640 2.95 45 16 28 Middle Frontal Gyrus
4 352  2.19 6 −4 60 Medial Frontal Gyrus
1.92  10 −2 56 Medial Frontal Gyrus
5  288 2.22 −42 −64 −22 Cerebellum (declive)
6 288 2.34 −32 −46 38 Inferior Parietal Lobule
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Sig. 4. Signiﬁcant ALE contrasts (p < 0.05, uncorrected) due to attention and workin
ealthy controls (green). ALE clusters are projected on a standard anatomical temp
he  references to color in this ﬁgure legend, the reader is referred to the web versio
emory in this ALE meta-analysis. The included studies in MS
atients involved fMRI paradigms such as the PASAT and the
VSAT, comprising working memory as well as attention abilities
Cardinal et al., 2008; Forn et al., 2008; Nagels et al., 2005). Although
orking memory and attention are distinguishable constructs,
oth processes are highly interactive (Chun and Turk-Browne,
007; Gazzaley, 2011; Olivers et al., 2011; Burianová et al., 2012;
oodman et al., 2013). It is assumed that attention proceduresctively participate in the manipulation and updating of working
emory contents (for review see Awh et al., 2006). In different
ubtypes of MS  especially PASAT served to detect and observe
mpairment of working memory and attention which have been
able 5
igniﬁcant ALE values for the contrast patients > healthy.
Cluster number Cluster volume (mm3) ALE value 
1 320 2.66 
2.49  
2 296  2.04 
1.87  
1.76  mory tasks in healthy controls versus MS patients (red) and in MS patients versus
colin1.1.nii) in axial orientation, referring to Talairach space. (For interpretation of
is article.)
identiﬁed  among other cognitive deﬁcits even at early stages of
the disease (Deloire et al., 2005; Huijbregts et al., 2006). With large
batteries of neuropsychological tests differences between cogni-
tive impairment in PPMS and RRMS have been presented. Impaired
information processing speed, attention, working memory, exec-
utive function, and verbal episodic memory have been identiﬁed
in PPMS whereas in RRMS only information processing speed and
working memory were impaired in comparison to healthy controls
(Ruet et al., 2013). Restricted performance in working memory
and attention related tasks has been indicated to be signiﬁcantly
associated with lesion load on structural MR  images of the brain
(Deloire et al., 2005).
Talairach coordinates Anatomical label
x y z
−42 18 18 Middle Frontal Gyrus
−46 18 20 Middle Frontal Gyrus
50 3 43 Middle Frontal Gyrus
53 1 38 Precentral Gyrus
45 3 40 Middle Fontal Gyrus
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Besides task-based functional imaging studies, patients with MS
ave increasingly been inspected using resting-state connectivity
easures. Recently, systematic alterations of functional connectiv-
ty in resting-state networks have been identiﬁed in patients with
S.  Characteristic modiﬁcations of functional connectivity at rest
ave been identiﬁed for the default mode network (Bonavita et al.,
011; Rocca et al., 2010), as well as for the sensorimotor network
Lowe et al., 2008), claiming changes already in very early stages
f the disease (Faivre et al., 2012). Speciﬁc alterations of functional
etworks in patients with MS  have been hypothesized to serve as an
maging biomarker for different cognitive functions, such as work-
ng memory (Sumowski et al., 2012) or attention (Loitfelder et al.,
012).
In this meta-analysis 17 signiﬁcant ALE clusters were obtained
or healthy controls. In contrast, the ALE analysis for MS  patients
evealed 24 signiﬁcant clusters. The increased number of ALE
lusters among MS  patients might be explained by overreach-
ng compensatory mechanisms, which have also been found for
ognitive impairments in various diseases, such as major depres-
ion (Diener et al., 2012) or Alzheimer’s disease (Browndyke et al.,
013). The results of this ALE meta-analysis revealed an increased
ikelihood of activation in the left VLPFC inducing an increased acti-
ation of the ventral attention network (VAN) compared to healthy
ontrols, which showed more activation in the dorsal attention
etwork (DAN). Findings of previous studies further point out the
nvolvement of two different neural networks (Fox et al., 2006) in
ttention processes, which cover different components of attention
Corbetta et al., 2000; Hopﬁnger et al., 2000). The dorsal pathway is
ctivated by expectation and anticipation, whereby top-down sig-
als are transmitted to the sensory cortex (Hopﬁnger et al., 2000;
iesbrecht et al., 2003). In contrast, the ventral system is not pre-
ctivated by expectation but plays an important role in reorienting
ttention based on new information (Serences et al., 2005; Shulman
t al., 2009), reﬂecting a stimulus-driven bottom-up process (forocedure. ALE clusters are projected on a standard anatomical template (colin1.1.nii)
review  see Corbetta et al., 2008). Although both systems cover dif-
ferent aspects of attention, these networks interact in a systematic
way (Kincade et al., 2005; Weissman and Prado, 2012; Wen  et al.,
2012). It is assumed that the interaction between the dorsal and
the ventral system contributes to some sort of reorienting atten-
tion (for review see Corbetta et al., 2008). One reason for poorer
performance of MS  patients in the PASAT task may be a lack of
preparatory expectation, reﬂected by an increased activation of
the VAN in MS  patients compared to healthy controls. Expecta-
tions based on pre-existing information contribute to simpliﬁcation
of decision by excluding unlikely events (Hopﬁnger et al., 2000;
Astaﬁev et al., 2003). In MS  patients, the DAN is less pre-activated
by expectation, which may  contribute to poorer performance in
attention and working memory tasks.
Previous functional imaging studies revealed right hemisphere
lateralization of the ventral pathway in healthy adults (Arrington
et al., 2000; Corbetta et al., 2000; Downar et al., 2001; Fox et al.,
2006). The results of the meta-analysis presented an increased
likelihood of activation in the left VLPFC in the MS  patient group
compared to healthy controls, in which typical right hemisphere
dominance was obtained. Atypical brain lateralization of cognitive
functions has been detected in several neurological and psychiatric
diseases such as autism (Lindell and Hudry, 2013), schizophre-
nia (Deep-Soboslay et al., 2010), or dyslexia (Leonard et al., 2006;
for review see Rentería, 2012). It has been revealed that also
anatomical differences in the human brain may  indicate signiﬁcant
functional changes already in the fetus (Kasprian et al., 2011). Atyp-
ical lateralization of cognitive function may therefore potentially
predict disease progression already in early stages.4.1. Limitations
Although meta-analyses present a powerful method to calcu-
late the statistical overlap between individual functional imaging
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tudies, all data reducing approaches suffer from inherent draw-
acks. The ALE technique, as all other meta-analysis techniques,
s unable to assess subtle methodological differences in individ-
al studies, or differences in preprocessing steps. However, it can
e assumed that these potential errors do not systematically inﬂu-
nce the results of a meta-analysis. In addition, sample size and
umber of reported foci are included into ALE algorithm (Eickhoff
t al., 2009; Turkeltaub et al., 2012), therefore no individual study is
ble to bias the ALE analysis signiﬁcantly (Turkeltaub et al., 2002). It
hould be recognized that meta-analyses are based upon previously
ublished studies. However, studies without signiﬁcant results or
ndings contradictory to the dominating opinion in a speciﬁc ﬁeld
f science may  never be prepared for publication, what may  cause a
ystematic overestimation of the results. MS  patients usually show
eterogeneous clinically symptoms, therefore, we  deﬁned strict
nclusion criteria to create a data set, as homogeneous as possible.
s a result, only nine studies fulﬁlled all criteria. Although the ALE
lgorithm controls for sample size of single studies and number of
eported foci, calculations on a relatively small data set may  result
n increased inﬂuence of one single study on the results of the meta-
nalysis. Therefore, we monitored the impact of each study using a
eave-one-out cross-validation procedure, in which no dominance
f one single study was evident.
Multiple sclerosis is a complex and multi-layered disease with
arious disease speciﬁc inﬂuencing factors, such as age, disease
ype, and duration or type of medication, resulting in very inho-
ogeneous patient groups. Especially the age and the disease
uration are correlated with the type of disease, as the SPMS type
equires a longer duration until the onset of disease until it can
e diagnosed. Therefore, generalized conclusions regarding dis-
ase progression based on ﬁndings of functional imaging studies
re difﬁcult. It has been shown that different aspects of cogni-
ion are impaired in different subtypes of MS  (Ruet et al., 2013).
ombining the results of studies including different phenotypes of
S  is necessary in order to be able to analyze data cumulatively.
MRI data acquired in RRMS, RPMS, and SPMS were combined in
he original studies as well as in our meta-analysis at the cost
f sensitivity to differences in activation between these pheno-
ypes.
.2. Future directions
In  multiple sclerosis the exact diagnosis, especially in early
tages of the disease is challenging. Therefore the acquisition and
ombination of different indicators, such as lesion load, functional
nd structural information is of huge importance. However, in
S patient groups are typically inhomogeneous with respect to
ge, disease duration, or type of disease, therefore the develop-
ent of new functional or structural biomarkers for diagnosis
nd disease progression is complicated. The aim of this meta-
nalysis was to summarize previous results of working memory
nd attention abilities in patients with MS  to enable a general view
n cognitive dysfunction in this disease. To gain more detailed
nsight into differences between disease subtypes concerning cog-
itive impairment and cognition related brain activation, studies
ncluding large patient groups of different subtypes are required.
urthermore, the resulting ALE maps will be provided online
http://www.meduniwien.ac.at/user/veronika.schoepf), and can
e used as masks for further ROI analyses.onﬂict of interest
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